Medical Imaging: Reagents and Analysis Tools

Published by: BCC Research

Published: Dec. 1, 2006 - 140 Pages

Table of Contents

INTRODUCTION

STUDY GOAL AND OBJECTIVES

SCOPE AND FORMAT

METHODOLOGY AND INFORMATION SOURCES

ABOUT THE AUTHOR

RELATED BCC REPORTS

BCC ONLINE SERVICES

DISCLAIMER

SUMMARY

IMAGING REAGENTS

Summary Table: U.S. MARKET FORECAST FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Summary Figure: U.S. MARKET FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY SEGMENT, 2002-2011 ($ MILLIONS)

IMAGE ANALYSIS SOFTWARE

MEDICAL IMAGE MANAGEMENT SYSTEMS

OVERVIEW

INTRODUCTION TO MEDICAL IMAGING

THE ROLE OF IMAGING REAGENTS

THE ROLE OF IMAGE ANALYSIS

THE ROLE OF IMAGE ARCHIVING AND MANAGEMENT

OVERVIEW OF IMAGING MODALITIES

ULTRASOUND IMAGING

3D Ultrasound Imaging

Doppler Ultrasound

COMMON MEDICAL USES OF ULTRASOUND IMAGING

Obstetrics

Oncology

Cardiovascular Imaging

Gastrointestinal and Other

Table 1 COMMON MEDICAL USES OF ULTRASOUND

MAGNETIC RESONANCE IMAGING

Safety

COMMON MEDICAL USES OF MRI

Cardiovascular

Oncology

Central Nervous System

Table 2 COMMON MEDICAL USES OF MRI

Functional MRI

Table 3 ADVANTAGES OF FUNCTIONAL MRI

X-RAY AND FLUOROSCOPY

COMMON MEDICAL USES

Table 4 COMMON MEDICAL USES OF X-RAY AND FLUOROSCOPY

COMPUTED TOMOGRAPHY

COMMON MEDICAL USES OF COMPUTER TOMOGRAPHY IMAGING

Cranial CT

Chest CT

Cardiac CT

Abdominal CT

Trauma

Oncology

Table 5 COMMON MEDICAL USES OF COMPUTED TOMOGRAPHY

IMAGE ANALYSIS

NUCLEAR MEDICINE

COMMON MEDICAL USES OF NUCLEAR MEDICINE

Oncology

Neurology

Cardiology

Cognitive Science

Pharmacology

Table 6 COMMON MEDICAL USES OF NUCLEAR MEDICINE

TECHNOLOGY

IMAGING REAGENTS

REPLACING MORE INVASIVE PROCEDURES

Brachytherapy

REDUCING COSTS

SAFETY

EARLY DETECTION

IMAGE ANALYSIS AND COMMUNICATION

DIGITALIZATION

EFFICIENT DATA FLOW WITHIN HOSPITAL

ACCESS TO SPECIALIZED CARE

REDUCING ERRORS AND LOST DATA

Reduced Cost of Archiving

RECENT ADVANCES IN IMAGING REAGENTS

NANOPARTICLES FOR ULTRASOUND IMAGING

NANOPARTICLES FOR MRI IMAGING

RECENT ADVANCES IN IMAGE ANALYSIS

ALGORITHMS FOR IMAGE-GUIDED SURGERY

PORTABLE AND HANDHELD IMAGING

RECENT ADVANCES IN IMAGE MANAGEMENT

PATENT ANALYSIS

PATENTS BY TECHNOLOGY

Table 7 IMAGING PRODUCT PATENTS ISSUED BY TECHNOLOGY, 2003-2006

Figure 1 IMAGING PRODUCT PATENTS BY TECHNOLOGY, 2003-2006 (%)

PATENTS BY IMAGING MODALITY

Table 8 IMAGING PRODUCT PATENTS BY IMAGING MODALITY 2003-2006

Figure 2 IMAGING PRODUCT PATENTS BY TECHNOLOGY, 2003-2006 (%)

PATENTS BY MEDICAL APPLICATION

Table 9 IMAGING PRODUCT PATENTS BY MEDICAL APPLICATION 2003-2006

Figure 3 IMAGING PRODUCT PATENTS BY MEDICAL APPLICATION, 2003-2006 (%)

PATENTS BY COUNTRY

Table 10 IMAGING PRODUCT PATENTS BY COUNTRY, 2003-2006

Figure 4 IMAGING PRODUCT PATENTS, 2003-2006 (%)

PATENTS BY ASSIGNEE

Table 11 IMAGING PRODUCT PATENTS BY ASSIGNEE AFFILIATION, 2003-2006

Figure 5 IMAGING PRODUCT PATENTS BY ASSIGNEE AFFILIATION, 2003-2006 (%)

PATENTS OF INTEREST

Significant Patents in Image Processing

Significant Patents in Imaging Reagents

Significant Patents in Image Archiving/ Communicating/Management

REGULATORY ASPECTS

REGULATION OF IMAGING REAGENTS

REGULATION OF IMAGING MANAGEMENT SYSTEMS

MARKET FOR MEDICAL IMAGING BY TECHNOLOGY

Table 12 U.S. MARKET FOR IMAGING AGENTS AND ANALYSIS TOOLS BY SEGMENT, THROUGH 2011, ($ MILLIONS)

IMAGING REAGENTS

Table 13 U.S. MARKET FOR MEDICAL IMAGING REAGENTS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Figure 6 U.S. MARKET FOR MEDICAL IMAGING REAGENTS BY SEGMENT, 2002-2011 ($ MILLIONS)

REAGENTS FOR ULTRASOUND IMAGING

Table 14 U.S. MARKET FOR ULTRASOUND IMAGING REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Microbubble Contrast Media

Liposome Contrast Media

Ultrasound Gels

Table 15 MAJOR ULTRASOUND REAGENTS AND MANUFACTURERS

REAGENTS FOR MRI IMAGING

Table 16 MAJOR MANUFACTURERS OF MRI CONTRAST AGENTS

Table 17 U.S. MARKET FOR MRI IMAGING REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Gadolinium Contrast

Iron Oxide

Manganese Chelates

REAGENTS FOR X-RAY IMAGING

Table 18 U.S. MARKET FOR X-RAY/FLUOROSCOPY REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Barium

Iodine

Table 19 MAJOR X-RAY REAGENTS AND MANUFACTURERS

REAGENTS FOR COMPUTED TOMOGRAPHY

Table 20 U.S. MARKET FOR COMPUTED TOMOGRAPHY REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Table 21 MAJOR COMPUTED TOMOGRAPHY REAGENTS AND MANUFACTURERS

REAGENTS FOR NUCLEAR MEDICINE IMAGING

Table 22 U.S. MARKET FOR NUCLEAR MEDICINE IMAGING REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Table 23 MAJOR NUCLEAR MEDICINE REAGENTS AND USES

MARKET FOR MEDICAL IMAGING ANALYSIS TOOLS

Table 24 U.S. MARKET FOR IMAGING ANALYSIS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Figure 7 U.S. MARKET FOR IMAGING ANALYSIS BY SEGMENT, 2002-2011 ($ MILLIONS)

ANALYTICAL TOOLS FOR ULTRASOUND IMAGING

Contrast-enhanced Doppler imaging

Contrast Harmonic Imaging

Intermittent Imaging

Doppler Ultrasonography

Gray-scale Enhancement

Transcranial Ultrasound

ANALYTICAL TOOLS FOR MRI IMAGING

Neurosurgical Planning

Functional Mapping for Chronic Pain

Physiological Basis of Neurological Disorders

Cognitive Science

ANALYTICAL TOOLS FOR X-RAY/CT IMAGING

Segmentation and Deconvolution

Skeletonization and Noise-reduction

Feature Recognition Algorithms

Statistical quantification of measured parameters

ANALYTICAL TOOLS FOR NUCLEAR MEDICINE

PET Standardization

MARKET FOR IMAGE MANAGEMENT SYSTEMS

Table 25 U.S. MARKET FOR IMAGING MANAGEMENT SYSTEMS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Figure 8 U.S. MARKET FOR IMAGING MANAGEMENT SYSTEMS BY SEGMENT, 2002-2011 ($ MILLIONS)

U.S. MARKET FOR IMAGING PRODUCTS, BY MEDICAL APPLICATION

Table 26 U.S. MARKET FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY APPLICATION, THROUGH 2011 ($ MILLIONS)

Figure 9 U.S. MARKET FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY APPLICATION, 2002-2011($ MILLIONS)

Figure 10 U.S. MARKET SHARE FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY APPLICATION, 2002-2011 (%)

ONCOLOGY

LUNG CANCER AND CT

VIRTUAL COLONOSCOPY

Table 27 COMMON IMAGING PROCEDURES IN ONCOLOGY

CARDIOVASCULAR IMAGING

Table 28 COMMON PROCEDURES FOR IMAGING THE CARDIOVASCULAR SYSTEM

CENTRAL NERVOUS SYSTEM

Table 29 COMMON PROCEDURES FOR IMAGING THE CENTRAL NERVOUS SYSTEM

GASTROINTESTINAL IMAGING

Table 30 COMMON PROCEDURES FOR IMAGING THE GASTROINTESTINAL SYSTEM

OBSTETRICS

Table 31 COMMON IMAGING PROCEDURES IN OBSTETRICS

MUSCULOSKELETAL SYSTEM

Table 32 COMMON PROCEDURES IN MUSCULOSKELETAL IMAGING

COMPANY PROFILES

ACUSPHERE

ADVANCED MAGNETICS, INC.

AGFA-GEVAERT CORP.

ALLIANCE PHARMACEUTICAL CORP.

ALOKA CO., LTD.

BARCO, INC.

BERLEX LABORATORIES

BRACCO DIAGNOSTICS, INC.

CMT MEDICAL SYSTEMS

CYTOGEN CORPORATION

DALSA CORPORATION

DENDRITIC NANOTECHNOLOGY

DIGIRAD CORP.

DRAXIS PHARMACEUTICALS

E-Z-EM, INC.

EPIX, INC.

ESAOTE/BIOSOUND ESAOTE, INC.

FUJIFILM MEDICAL SYSTEMS

GENERAL ELECTRIC HEALTHCARE/GE HEALTHCARE BIO-SCIENCES CORP.

ICAD

IMAGING DIAGNOSTIC SYSTEMS, INC.

KEY EXECUTIVES

IMARX THERAPEUTICS

INSITEONE, INC.

EASTMAN KODAK CO.

LIVEDATA, INC.

MALLINCKRODT MEDICAL

MCKESSON PROVIDER TECHNOLOGIES

MEDRAD, INC.

MERGE EMED, INC.

MIRABEL MEDICAL SYSTEMS, INC.

POINT BIOMEDICAL

R2 TECHNOLOGY, INC./HOLOGIC, INC.

RIS CONCEPTS, INC.

SCANIS

SCHERING AG

SECTRA

SIEMENS MEDICAL SOLUTIONS

SWISSRAY INTERNATIONAL, INC.

VIATRONIX, INC.

VIDAR SYSTEMS CORP.

VITAL IMAGES

MARKET SHARE

U.S. MARKET SHARE OF IMAGING REAGENTS

Table 33 U.S. MARKET SHARE OF COMPANIES IN IMAGING REAGENTS, 2006 (%)

Figure 11 U.S. MARKET SHARE OF COMPANIES IN IMAGING REAGENTS, 2006 (%)

MARKET SHARE OF IMAGING ANALYSIS TOOLS

Table 34 U.S. MARKET SHARE OF COMPANIES IN IMAGE ANALYSIS TOOLS, 2006 (%)

Figure 12 U.S. MARKET SHARE OF COMPANIES IN IMAGE ANALYSIS TOOLS, 2006 (%)

MARKET SHARE OF IMAGE MANAGEMENT SYSTEMS

Table 35 U.S. MARKET SHARE OF COMPANIES IN IMAGE MANAGEMENT SYSTEMS, 2006 (%)

Figure 13 U.S. MARKET SHARE OF COMPANIES IN IMAGE MANAGEMENT SYSTEMS, 2006 (%)

LIST OF TABLES

Summary Table: U.S. MARKET FORECAST FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Table 1 COMMON MEDICAL USES OF ULTRASOUND

Table 2 COMMON MEDICAL USES OF MRI

Table 3 ADVANTAGES OF FUNCTIONAL MRI

Table 4 COMMON MEDICAL USES OF X-RAY AND FLUOROSCOPY

Table 5 COMMON MEDICAL USES OF COMPUTED TOMOGRAPHY

Table 6 COMMON MEDICAL USES OF NUCLEAR MEDICINE

Table 7 IMAGING PRODUCT PATENTS ISSUED BY TECHNOLOGY, 2003-2006

Table 8 IMAGING PRODUCT PATENTS BY IMAGING MODALITY 2003-2006

Table 9 IMAGING PRODUCT PATENTS BY MEDICAL APPLICATION 2003-2006

Table 10 IMAGING PRODUCT PATENTS BY COUNTRY, 2003-2006

Table 11 IMAGING PRODUCT PATENTS BY ASSIGNEE AFFILIATION, 2003-2006

Table 12 U.S. MARKET FOR IMAGING AGENTS AND ANALYSIS TOOLS BY SEGMENT, THROUGH 2011, ($ MILLIONS)

Table 13 U.S. MARKET FOR MEDICAL IMAGING REAGENTS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Table 14 U.S. MARKET FOR ULTRASOUND IMAGING REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Table 15 MAJOR ULTRASOUND REAGENTS AND MANUFACTURERS

Table 16 MAJOR MANUFACTURERS OF MRI CONTRAST AGENTS

Table 17 U.S. MARKET FOR MRI IMAGING REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Table 18 U.S. MARKET FOR X-RAY/FLUOROSCOPY REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Table 19 MAJOR X-RAY REAGENTS AND MANUFACTURERS

Table 20 U.S. MARKET FOR COMPUTED TOMOGRAPHY REAGENTS BY PRODUCT, THROUGH 2011 ($ MILLIONS)

Table 21 MAJOR COMPUTED TOMOGRAPHY REAGENTS AND MANUFACTURERS

Table 22 U.S. MARKET FOR NUCLEAR MEDICINE IMAGING REAGENTS BY PRODUCT, THROUGH 2011 ($MILLIONS)

Table 23 MAJOR NUCLEAR MEDICINE REAGENTS AND USES

Table 24 U.S. MARKET FOR IMAGING ANALYSIS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Table 25 U.S. MARKET FOR IMAGING MANAGEMENT SYSTEMS BY SEGMENT, THROUGH 2011 ($ MILLIONS)

Table 26 U.S. MARKET FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY APPLICATION, THROUGH 2011 ($ MILLIONS)

Table 27 COMMON IMAGING PROCEDURES IN ONCOLOGY

Table 28 COMMON PROCEDURES FOR IMAGING THE CARDIOVASCULAR SYSTEM

Table 29 COMMON PROCEDURES FOR IMAGING THE CENTRAL NERVOUS SYSTEM

Table 30 COMMON PROCEDURES FOR IMAGING THE GASTROINTESTINAL SYSTEM

Table 31 COMMON IMAGING PROCEDURES IN OBSTETRICS

Table 32 COMMON PROCEDURES IN MUSCULOSKELETAL IMAGING

Table 33 U.S. MARKET SHARE OF COMPANIES IN IMAGING REAGENTS, 2006 (%)

Table 34 U.S. MARKET SHARE OF COMPANIES IN IMAGE ANALYSIS TOOLS, 2006 (%)

Table 35 U.S. MARKET SHARE OF COMPANIES IN IMAGE MANAGEMENT SYSTEMS, 2006 (%)

LIST OF FIGURES

Summary Figure: U.S. MARKET FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY SEGMENT, 2002-2011 ($ MILLIONS)

Figure 1 IMAGING PRODUCT PATENTS BY TECHNOLOGY, 2003-2006 (%)

Figure 2 IMAGING PRODUCT PATENTS BY TECHNOLOGY, 2003-2006 (%)

Figure 3 IMAGING PRODUCT PATENTS BY MEDICAL APPLICATION, 2003-2006 (%)

Figure 4 IMAGING PRODUCT PATENTS, 2003-2006 (%)

Figure 5 IMAGING PRODUCT PATENTS BY ASSIGNEE AFFILIATION, 2003-2006 (%)

Figure 6 U.S. MARKET FOR MEDICAL IMAGING REAGENTS BY SEGMENT, 2002-2011 ($ MILLIONS)

Figure 7 U.S. MARKET FOR IMAGING ANALYSIS BY SEGMENT, 2002-2011 ($ MILLIONS)

Figure 8 U.S. MARKET FOR IMAGING MANAGEMENT SYSTEMS BY SEGMENT, 2002-2011 ($ MILLIONS)

Figure 9 U.S. MARKET FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY APPLICATION, 2002-2011 ($ MILLIONS)

Figure 10 U.S. MARKET SHARE FOR IMAGING REAGENTS AND ANALYSIS TOOLS BY APPLICATION, 2002-2011 (%)

Figure 11 U.S. MARKET SHARE OF COMPANIES IN IMAGING REAGENTS, 2006 (%)

Figure 12 U.S. MARKET SHARE OF COMPANIES IN IMAGE ANALYSIS TOOLS, 2006 (%)

Figure 13 U.S. MARKET SHARE OF COMPANIES IN IMAGE MANAGEMENT SYSTEMS, 2006 (%)

Abstract

• A detailed analysis of medical imaging, including supporting products that have enhanced imaging at the chemical (reagents and contrast media) and analytical (software tools and image management) levels
• Regulatory aspects important to the industry

• An examination of existing technology, the latest innovations and important patents
Profiles of the top companies within the industry.
• The U.S. market for medical imaging reagents and analysis tools is valued at a little more than $4.9 billion in 2006 and is expected to grow at an average annual growth rate of 11.9% to reach over $8.4 billion in 2011.


• Imaging reagents currently comprise the largest segment with a value of $2.97 billion in 2006. Medical imaging reagents are expected to increase at an average annual rate of 10.5% to reach $4.9 billion in 2011. The market for imaging reagents is currently led by radiopharmaceuticals for nuclear medicine imaging. The market for these reagents was over $1 billion in 2006 and is expected to grow with an average annual rate of 11.8% to surpass $1.7 billion in 2011. Ultrasound imaging reagents are expected to experience the most significant growth with an average annual rate of 36% to reach $252.8 million in 2011.
• Within the image analysis market, tools for the analysis of ultrasound images were $190.5 million in 2006 and are expected to grow at an average annual rate of 13.6% to reach $360.6 in 2011.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.